Fol. Biol. 2021, 67, 183-190
https://doi.org/10.14712/fb2021067050183
Over-expression of Apolipoprotein J Inhibits Cholesterol Crystal-Induced Inflammatory Responses via Suppressing NLRP3 Inflammasome Activation in THP-1 Macrophages
References
1. 2018) Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment. Mediators Inflamm. 18, ID 2453265.
, F., Anelli, M. G., Rinaldi, A., Fornaro, M., Lopalco, G., Scioscia, C., Lapadula, G., Iannone, F. (
2. 2010) An update on the role of markers of inflammation in atherosclerosis. J. Atheroscler. Thromb. 17, 1-11.
< , E., Rizzo, M., Coppola, G., Fattouch, K., Novo, G., Marturana, I., Ferrara, F., Novo, S. (https://doi.org/10.5551/jat.2600>
3. 2014) The anti-atherosclerotic effect of tanshinone IIA is associated with the inhibition of TNF-α-induced VCAM-1, ICAM-1 and CX3CL1 expression. Phytomedicine 21, 207-216.
< , C, C., Chu, C. F., Wang, C. N., Wu, H. T., Bi, K. W., Pang, J. H., Huang, S. T. (https://doi.org/10.1016/j.phymed.2013.09.012>
4. 2010) The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One 5, e8668.
< , M., Preston, J. A., Marriott, H. M., Whyte, M. K., Dockrell, D. H. (https://doi.org/10.1371/journal.pone.0008668>
5. 1990) Apolipoprotein J: structure and tissue distribution. Biochemistry 29, 5380-5389.
< , H. V., Harmony, J. A., Stuart, W. D., Gil, C. M., Robbins, J. (https://doi.org/10.1021/bi00474a025>
6. 2010) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357-1361.
< , P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., Espevik, T., Lien, E., Fitzgerald, K. A., Rock, K. L., Moore, K. J., Wright, S. D., Hornung, V., Latz, E. (https://doi.org/10.1038/nature08938>
7. 1998) Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: a potential anti-atherogenic function? Biochem. J. 331 (Pt 1), 231-237.
< , I. C., Hochgrebe, T., Wilson, M. R., Easterbrook- Smith, S. B., Jessup, W., Dean, R. T., Brown, A. J. (https://doi.org/10.1042/bj3310231>
8. 2017) The immunology of atherosclerosis. Nat. Rev. Nephrol. 13, 368-380
< , A., Hansson, G. K. (https://doi.org/10.1038/nrneph.2017.51>
9. 2012) Presence, localization, and origin of clusterin in normal human spermatozoa. J. Assist. Reprod. Genet. 29, 751-757.
< , Z., Wang, Z., Cheng, G., Liu, B., Li, P., Li, J., Wang, W., Yin, C., Zhang, W. (https://doi.org/10.1007/s10815-012-9779-x>
10. 2011) The immune system in atherosclerosis. Nat. Immunol. 12, 204-212.
< , G. K., Hermansson, A. (https://doi.org/10.1038/ni.2001>
11. 2015) Humanized anti-IFN-γ (HuZAF) in the treatment of psoriasis. J. Allergy Clin. Immunol. 135, 553-556.
< , J. L., Johnson-Huang, L. M., Chamian, M. F., Lee, E., Pearce, T., Leonardi, C. L., Haider, A., Lowes, M. A., Krueger, J. G. (https://doi.org/10.1016/j.jaci.2014.05.046>
12. 1991) Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma. J. Biol. Chem. 266, 11030-11036.
< , D. E., Lowin, B., Peitsch, M. C., Böttcher, A., Schmitz, G., Tschopp, J. (https://doi.org/10.1016/S0021-9258(18)99123-4>
13. 1976) Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques. J. Clin. Invest. 58, 200-211.
< , S. S., Shipley, G. G., Small, D. M. (https://doi.org/10.1172/JCI108450>
14. 2009) Protective role of clusterin/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells. Arterioscler. Thromb. Vasc. Biol. 29, 1558-1564.
< , H. J., Yoo, E. K., Kim, J. Y., Choi, Y. K., Lee, H. J., Kim, J. K., Jeoung, N. H., Lee, K. U., Park, I. S., Min, B. H., Park, K. G., Lee, C. H., Aronow, B. J., Sata, M., Lee, I. K. (https://doi.org/10.1161/ATVBAHA.109.190058>
15. 2018) Clusterin reduces cold ischemia-reperfusion injury in heart transplantation through regulation of NF-kB signaling and Bax/Bcl-xL expression. Cell. Physiol. Biochem. 45, 1003-1012.
< , G., Zhang, H., Hao, F., Hao, J., Pan, L., Zhao, Q., Wo, J. (https://doi.org/10.1159/000487295>
16. 2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔ C(T)) method. Methods 25, 402-408.
< , K. J., Schmittgen, T. D. (https://doi.org/10.1006/meth.2001.1262>
17. 1999) MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. Eur. Heart J. 20, 725-741.
Heart Protection Study Collaborative Group (
18. 2020) Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis. EBioMedicine 60, 102985.
< , N., Bakke, S. S., Gregersen, I., Holm, S., Sandanger, Ø., Orrem, H. L., Sporsheim, B., Ryan, L., Kong, X. Y., Dahl, T. B., Skjelland, M., Sørensen, K. K., Rokstad, A. M., Yndestad, A., Latz, E., Gullestad, L., Andersen, G. Ø., Damås, J. K., Aukrust, P., Mollnes, T. E., Halvorsen, B., Espevik, T. (https://doi.org/10.1016/j.ebiom.2020.102985>
19. 2012) Cholesterol, inflammasomes, and atherogenesis. Curr. Cardiovasc. Risk Rep. 6, 45-52.
< , J. M., Ordovas, J. M. (https://doi.org/10.1007/s12170-011-0212-2>
20. 2015) Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives. J. Inflamm. Res. 8, 15-27.
, E., Campbell, M., Doyle, S. L. (
21. 2014) The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases. Rev. Endocr. Metab. Disord. 15, 45-53.
< , S., Mathis, K. W., Lee, I. K. (https://doi.org/10.1007/s11154-013-9275-3>
22. 2008) Apolipoprotein J and leptin levels in patients with coronary heart disease. In Vivo 22, 537-542.
, M. V., Paraskevas, K. I., Wilson, M. R., Iliopoulos, D. C., Tsigris, C., Mikhailidis, D. P., Perrea, D. (
23. 2010) Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One 5, e11765.
< , K., Lappalainen, J., Oörni, K., Välimäki, E., Matikainen, S., Kovanen, P. T., Eklund, K. K. (https://doi.org/10.1371/journal.pone.0011765>
24. 2018) Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS). Eur. Heart J. 39, 3499-3507.
< , P. M., Libby, P., MacFadyen, J. G., Thuren, T., Ballantyne, C., Fonseca, F., Koenig, W., Shimokawa, H., Everett, B. M., Glynn, R. J. (https://doi.org/10.1093/eurheartj/ehy310>
25. 2013) Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoproteinproteome remodeling. Circulation 127, 891-904.
< , M., Rohrer, L., Roschitzki, B., Besler, C., Mocharla, P., Mueller, M., Perisa, D., Heinrich, K., Altwegg, L., von Eckardstein, A., Lüscher, T. F., Landmesser, U. (https://doi.org/10.1161/CIRCULATIONAHA.112.108753>
26. 1999) Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia. Am. J. Obstet. Gynecol. 180, 587-592.
< , A. C., Ranheim, T., Khoury, J., Henriksen, T. (https://doi.org/10.1016/S0002-9378(99)70259-0>
27. 2012) Inflammasomes in health and disease. Nature 481, 278-286.
< , T., Henao-Mejia, J., Elinav, E., Flavell, R. (https://doi.org/10.1038/nature10759>
28. 2010) Intravenous clusterin administration reduces myocardial infarct size in rats. Eur. J. Clin. Invest. 40, 893-902.
< , A., Vermond, R. A., Krijnen, P. A., Juffermans, L. J., Hahn, N. E., Makker, S. P., Aarden, E., Hack, L. A., Spreeuwenberg, M., van Rossum, B. C., Meischl, C., Paulus, W. J., Van Milligen, F. J., Niessen, H. W. (https://doi.org/10.1111/j.1365-2362.2010.02345.x>
29. 2020) Total saponin of Dioscorea collettii attenuates MSU crystal‑induced inflammation via inhibiting the activation of the NALP3 inflammasome and caspase‑1 in THP‑1 macrophages. Mol. Med. Rep. 21, 2466-2474.
, L., Zhu, L., Duan, C., Li, L., Chen, G. (
30. 2014) Clusterin/Apolipoprotein J immunolocalization on carotid artery is affected by TNF-α, cigarette smoking and antiplatelet treatment. Lipids Health Dis. 13, 70.
< , A. E., Agrogiannis, G., Gkekas, C., Perrea, D. (https://doi.org/10.1186/1476-511X-13-70>